SELVAS Healthcare, Inc. (KOSDAQ:208370)

Market Cap	109.30B -5.7%
Revenue (ttm)	30.82B -2.8%
Net Income	3.89B +23.4%
EPS	151.00 +23.8%
Shares Out	25.72M
PE Ratio	28.15
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	140,146
Average Volume	953,805
Open	4,270.00
Previous Close	4,190.00
Day's Range	4,200.00 - 4,315.00
52-Week Range	3,405.00 - 7,490.00
Beta	-0.73
RSI	43.27
Earnings Date	Apr 3, 2026

About SELVAS Healthcare

SELVAS Healthcare, Inc. operates as a medical device company in South Korea. The company provides body composition analyzers and automatic blood pressure monitors for hospitals. It also offers Braille Sense notetakers and other products for blind and visually impaired people under the HIMS brand name, as well as provides digital health products under the ACCUNIQ brand name. In addition, The company provides daisy players, handheld, and desktop magnifiers. Its products are used in hospitals, medical facilities, doctor's offices, weight loss cent...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1993
• Employees: 128
• Stock Exchange: KOSDAQ
• Ticker Symbol: 208370

Financial Performance

In 2025, SELVAS Healthcare's revenue was 30.82 billion, a decrease of -2.77% compared to the previous year's 31.70 billion. Earnings were 3.89 billion, an increase of 23.39%.